RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,014 | -39.7% | 10,183 | -6.9% | 0.00% | – |
| Q4 2022 | $38,160 | -96.6% | 10,934 | -63.8% | 0.00% | -100.0% |
| Q3 2022 | $1,117,000 | +106.5% | 30,171 | +5.8% | 0.00% | +100.0% |
| Q2 2022 | $541,000 | -35.8% | 28,507 | -8.7% | 0.00% | 0.0% |
| Q1 2022 | $843,000 | +31.9% | 31,222 | +10.1% | 0.00% | 0.0% |
| Q4 2021 | $639,000 | +38.0% | 28,366 | +60.7% | 0.00% | 0.0% |
| Q3 2021 | $463,000 | -30.2% | 17,656 | -14.8% | 0.00% | 0.0% |
| Q2 2021 | $663,000 | -14.8% | 20,724 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $778,000 | +9.6% | 22,104 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $710,000 | -13.5% | 22,130 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $821,000 | -13.5% | 21,832 | +3.0% | 0.00% | -50.0% |
| Q2 2020 | $949,000 | – | 21,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 853,206 | $30,041,000 | 3.26% |
| COMMODORE CAPITAL LP | 161,565 | $5,689,000 | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $7,042,000 | 1.98% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,412 | $15,894,000 | 1.30% |
| Avoro Capital Advisors LLC | 1,525,000 | $53,695,000 | 0.93% |
| RTW INVESTMENTS, LP | 1,530,717 | $53,897,000 | 0.84% |
| Pegasus Asset Management, Inc. | 26,958 | $949,000 | 0.48% |
| COWEN AND COMPANY, LLC | 166,942 | $5,878,000 | 0.40% |
| Ikarian Capital, LLC | 290,207 | $10,218,000 | 0.34% |
| Spotlight Asset Group, Inc. | 24,565 | $865,000 | 0.32% |